A NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Singh, B. [1 ]
Sharma, A. [1 ]
Rai, P. [1 ]
Kaur, G. [1 ]
Pandey, S. [1 ]
机构：
[1] Pharmacoevidence, Sas Nagar Mohali, PB, India
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO67
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [1] NETWORK META-ANALYSIS OF FIRST-LINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: WHO IS THE WINNER?
    Celsa, C.
    Cabibbo, G.
    Rizzo, G. E. M.
    Giuffrida, P.
    Di Maria, G.
    Battaglia, S.
    Vaccaro, M.
    Enea, M.
    Giacchetto, C. M.
    Rancatore, G.
    Grassini, M., V
    Ciccia, R.
    Grova, A.
    Salvato, M.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S106 - S106
  • [2] Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: Who is the winner?
    Celsa, C.
    Cabibbo, G.
    Rizzo, G. E. M.
    Giuffrida, P.
    Enea, M.
    Di Maria, G.
    Antonucci, M.
    Giacchetto, C. M.
    Rancatore, G.
    Grassini, M. V.
    Ciccia, R.
    Grova, A.
    Salvato, M.
    Battaglia, S.
    Vaccaro, M.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S3 - S3
  • [3] A parametric network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma related to overall survival
    Sharma, A.
    Singh, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S616 - S617
  • [4] Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
    Yue Han
    Wei-Hua Zhi
    Fei Xu
    Chen-Bo Zhang
    Xiao-Qian Huang
    Jian-Feng Luo
    World Journal of Gastroenterology, 2021, 27 (19) : 2415 - 2433
  • [5] Network meta-analysis of first-line systemic therapies for advanced hepatocellular carcinoma: A comparison of objective response rates
    Kaur, G.
    Singh, B.
    Attri, S.
    Sharma, A.
    Rai, P.
    Pandey, S.
    ANNALS OF ONCOLOGY, 2023, 34 : S616 - S616
  • [6] Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
    Han, Yue
    Zhi, Wei-Hua
    Xu, Fei
    Zhang, Chen-Bo
    Huang, Xiao-Qian
    Luo, Jian-Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (19) : 2415 - 2433
  • [7] First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
    Fong, Khi Yung
    Zhao, Joseph Jonathan
    Sultana, Rehena
    Lee, Joycelyn Jie Xin
    Lee, Suat Ying
    Chan, Stephen Lam
    Yau, Thomas
    Tai, David Wai Meng
    Sundar, Raghav
    Too, Chow Wei
    LIVER CANCER, 2023, 12 (01) : 7 - 18
  • [8] The emerging therapies are reshaping the first-line treatment for advanced hepatocellular carcinoma: a systematic review and network meta-analysis
    Peng, Wei
    Pan, Yangxun
    Xie, Lan
    Yang, Zhoutian
    Ye, Zhiwei
    Chen, Jinbin
    Wang, Juncheng
    Hu, Dandan
    Xu, Li
    Zhou, Zhongguo
    Chen, Minshan
    Fang, Aiping
    Zhang, Yaojun
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [9] First-line systemic treatment for hepatocellular carcinoma: A systematic review and network meta-analysis
    Ciliberto, Domenico
    Carid, Giulio
    Staropoli, Nicoletta
    Romeo, Caterina
    Arillotta, Grazia Maria
    Napoli, Cristina
    Gervasi, Luigia
    Luciano, Francesco
    Riillo, Caterina
    Tassone, Pierfrancesco
    Tagliaferri, Pierosandro
    HELIYON, 2023, 9 (08)
  • [10] Evaluation of first-line systemic treatments for unresectable hepatocellular carcinoma (uHCC): A network meta-analysis
    Zhi, W.
    Xu, F.
    Luo, J.
    Zhang, C.
    Huang, X.
    Han, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1310 - S1310
12345